Tradestie Institutional Equity Comparison Engine

VCYT vs TXG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while TXG counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus TXG at N/M Forward P/E and -10.6% operating margin (+1.1% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against TXG sits in CONSOLIDATION (42nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
VCYT 15.3x vs TXG N/M Fwd P/E
Growth & Margin Winner VCYT
Op Margin 15.0% vs -10.6% ยท YoY +15.1% vs +1.1%
Momentum & Technical Winner TXG
1Y -39.8% vs +236.3% ยท 52W Pos 5% vs 46%
Options & Structure Winner TXG
BREAKDOWN (47th %ile IV) vs CONSOLIDATION (42nd %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
TXG NASDAQ
10x Genomics, Inc. Class A Common Stock
Laboratory Analytical Instruments
$54.99
-5.5% 1D
Market Cap $7.7B
1M Return -21.29%
1Y Return +236.33%
Forward P/E N/M
Unified AI Score
50.5 / 100 HOLD
Tech 40.0 Fund 51.0 Flow 54.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -39.78% TXG +236.33% Spread: +276.11 pp (TXG Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue TXG Revenue VCYT Op. Margin TXG Op. Margin Margin Edge
FY2018 $90M $150M -24.2% -75.7% VCYT
FY2019 $120M $250M -12.6% -12.4% TXG
FY2020 $120M $300M -30.1% -178.7% VCYT
FY2021 $220M $490M -37.3% -10.7% TXG
FY2022 $300M $520M -13.9% -32.5% VCYT
FY2023 $360M $620M -23.8% -42.9% VCYT
FY2024 $450M $610M 3.6% -31.9% VCYT
FY2025 $520M $640M 11.2% -9.5% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (6) vs TXG (4)
Institutional Metric VCYT TXG Criterion Row Winner
Market Capitalization Scale $2.0B $7.7B Larger Scale TXG
Trailing P/E Ratio Valuation 15.8x N/M Lower Multiple VCYT
Forward P/E Ratio Valuation 15.3x N/M Lower Multiple VCYT
Revenue Growth (YoY) Growth +15.1% +1.1% Higher Growth VCYT
Operating Margin (TTM) Profitability 15.0% -10.6% Higher Margin VCYT
Net Profit Margin Profitability 21.8% -10.8% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency 9.4% -8.3% Higher ROE VCYT
52-Week Range Position Momentum 5% ($22โ€“$61) 46% ($15โ€“$103) Stronger Trend TXG
Beta / 30D Volatility Risk Regime 3.01ฮฒ ยท 199% Vol 2.70ฮฒ ยท 109% Vol Lower Realized Risk TXG
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 50.5 / 100 (HOLD) Higher Composite TXG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs TXG Buy Guide
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TXG CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live TXG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor TXG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.